Annual Short Term Debt
$902.00 K
+$34.00 K+3.92%
31 December 2023
Summary:
Y-mAbs Therapeutics annual short term debt is currently $902.00 thousand, with the most recent change of +$34.00 thousand (+3.92%) on 31 December 2023. During the last 3 years, it has fallen by -$1.06 million (-54.12%). YMAB annual short term debt is now -54.12% below its all-time high of $1.97 million, reached on 31 December 2020.YMAB Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$776.00 K
-$66.00 K-7.84%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly short term debt is currently $776.00 thousand, with the most recent change of -$66.00 thousand (-7.84%) on 30 September 2024. Over the past year, it has dropped by -$122.00 thousand (-13.59%). YMAB quarterly short term debt is now -61.47% below its all-time high of $2.01 million, reached on 30 June 2021.YMAB Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | -13.6% |
| 3 y3 years | -54.1% | -58.0% |
| 5 y5 years | +100.0% | +50.4% |
YMAB Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.1% | +3.9% | -58.0% | at low |
| 5 y | 5 years | -54.1% | -61.5% | +50.4% | |
| alltime | all time | -54.1% | -61.5% |
Y-mAbs Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $776.00 K(-7.8%) |
| June 2024 | - | $842.00 K(-5.2%) |
| Mar 2024 | - | $888.00 K(-1.6%) |
| Dec 2023 | $902.00 K(+3.9%) | $902.00 K(+0.4%) |
| Sept 2023 | - | $898.00 K(+8.3%) |
| June 2023 | - | $829.00 K(-3.0%) |
| Mar 2023 | - | $855.00 K(-1.5%) |
| Dec 2022 | $868.00 K(-51.3%) | $868.00 K(-27.7%) |
| Sept 2022 | - | $1.20 M(+9.9%) |
| June 2022 | - | $1.09 M(-24.7%) |
| Mar 2022 | - | $1.45 M(-18.6%) |
| Dec 2021 | $1.78 M | $1.78 M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.85 M(-8.2%) |
| June 2021 | - | $2.01 M(+2.2%) |
| Mar 2021 | - | $1.97 M(+0.3%) |
| Dec 2020 | $1.97 M(+281.0%) | $1.97 M(+4.2%) |
| Sept 2020 | - | $1.89 M(+231.6%) |
| June 2020 | - | $569.00 K(+3.8%) |
| Mar 2020 | - | $548.00 K(+6.2%) |
| Dec 2019 | $516.00 K(>+9900.0%) | $516.00 K(0.0%) |
| Sept 2019 | - | $516.00 K(+2.8%) |
| June 2019 | - | $502.00 K(-2.9%) |
| Mar 2019 | - | $517.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Y-mAbs Therapeutics annual short term debt?
- What is the all time high annual short term debt for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual short term debt year-on-year change?
- What is Y-mAbs Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly short term debt year-on-year change?
What is Y-mAbs Therapeutics annual short term debt?
The current annual short term debt of YMAB is $902.00 K
What is the all time high annual short term debt for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual short term debt is $1.97 M
What is Y-mAbs Therapeutics annual short term debt year-on-year change?
Over the past year, YMAB annual short term debt has changed by +$34.00 K (+3.92%)
What is Y-mAbs Therapeutics quarterly short term debt?
The current quarterly short term debt of YMAB is $776.00 K
What is the all time high quarterly short term debt for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly short term debt is $2.01 M
What is Y-mAbs Therapeutics quarterly short term debt year-on-year change?
Over the past year, YMAB quarterly short term debt has changed by -$122.00 K (-13.59%)